The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders
Open accessAbstract
Background— The beneficial effect of immunosuppressive treatment on myocarditis is still controversial, possibly because the immunologic and virological profile of potential candidates is largely unknown. Methods and Results— Out of 652 biopsied patients, 112 had a histological diagnosis of active lymphocytic myocarditis; 41 of these 112 patients were characterized by progressive heart failure despite conventional therapy and were treated with prednisone and azathioprine for 6 months. All were resubmitted to cardiac catheterization, angiography, and endomyocardial biopsy at 1 and 6 months and followed-up for 1 year. A total of 21 patients responded with prompt improvement in left ventricular ejection fraction from 25.7±4.1% to 47.1±4.4% and showed evidence of healed myocarditis at control biopsy. Conversely, 20 patients failed to respond and showed a histological evolution toward dilated cardiomyopathy: 12 remained stationary, 3 underwent cardiac transplantation, and 5 died. We retrospectively performed a polymerase chain reaction on frozen endomyocardial tissue for the most common cardiotropic viruses and assessed circulating serum cardiac autoantibodies. Viral genomes were present in biopsy specimens of 17 nonresponders (85%), including enterovirus (n=5), Epstein-Barr virus (n=5) adenovirus (n=4), both adenovirus and enterovirus (n=1), influenza A virus (n=1), parvovirus-B19 (n=1), and in 3 responders, who were all positive for hepatitis C virus. Cardiac autoantibodies were present in 19 responders (90%) and in none of the nonresponders. Conclusions— In patients with active lymphocytic myocarditis, those with circulating cardiac autoantibodies and no viral genome in the myocardium are the most likely to benefit from immunosuppression. The beneficial effect of immunosuppression in hepatitis C virus myocarditis suggests a relevant immunomediated component of damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“suggesting potential alternative pathogenesis such as autoimmunity, hypersensitivity, or medication usage.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [152]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Notably, in some cases of lymphocytic myocarditis, these viruses tested negative, while autoantibodies specific to the heart were present”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [152]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myocarditis. A histopathologic definition and classification.
Aretz, H. T., Billingham, M. E., Edwards, W. D., Factor, S. M., Fallon, J. T., Fenoglio, J. J., Olsen, E. G. J., & Schöen, F. J. (1987) · PubMed · Cited by 1,307
A Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274
Feldman, A. M., & McNamara, D. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 954
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Johnson, R. J., Gretch, D. R., Yamabe, H., Hart, J., Bacchi, C. E., Hartwell, P., Couser, W. G., Corey, L., Wener, M. H., Alpers, C. E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280703 · Cited by 870
Active Myocarditis in the Spectrum of Acute Dilated Cardiomyopathies
DEC, G. W., Palacios, I. F., Fallon, J. T., Aretz, H. T., Mills, J. L., Lee, D. C.-S., & Johnson, R. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121404 · Cited by 562
Advances in the Understanding of Myocarditis
Liu, P. P., & Mason, J. W. (2001) · Circulation · doi:10.1161/hc3401.095198 · Cited by 495
Wojnicz, R., Nowalany-Kozielska, E., Wojciechowska, C., Glanowska, G., Wilczewski, P., Niklewski, T., Zembala, M., Poloński, L., Rozek, M. M., & Wodniecki, J. (2001) · Circulation · doi:10.1161/01.cir.104.1.39 · Cited by 456
Acute myocarditis. Rapid diagnosis by PCR in children.
Martin, A. B., Webber, S. A., Fricker, F. J., Jaffe, R., Demmler, G. J., Kearney, D. L., Zhang, Y. H., Bodurtha, J., Gelb, B. D., & Ni, J. (1994) · Circulation · doi:10.1161/01.cir.90.1.330 · Cited by 409
A Prospective, Randomized, Controlled Trial of Prednisone for Dilated Cardiomyopathy
Parrillo, J. E., Cunnion, R. E., Epstein, S. E., Parker, M. M., Suffredini, A. F., Brenner, M., Schaer, G. L., Palmeri, S. T., Cannon, R. O., Alling, D. W., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910193211601 · Cited by 352
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy
Caforio, A. L. P., Bonifacio, E. E., Stewart, J. T., Neglia, D., Parodi, O., Bottazzo, G. F., & McKenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92821-i · Cited by 201
Research works printed but not linked: 10
Cited by
Sorted by citations
Items 301–400 of 462
Cardiomyopathies - The special entity of myocarditis and inflammatory cardiomyopathy
Escher, F., Kühl, U., Laßner, D., & Schultheiß, H. (2019) · Journal of Cardiology and Cardiovascular Medicine · doi:10.29328/journal.jccm.1001041 · Cited by 5
Hess, O. M., McKenna, W. J., & Schultheiß, H. (2009) · doi:10.1093/med/9780199566990.003.018 · Cited by 5
Endomyocardial Biopsy: A Clinical Research Tool and a Useful Diagnostic Method
Gonz�lez, J. F., Salgado, F., Azzato, F., Ambrosio, G., & Milei, J. (2013) · InTech eBooks · doi:10.5772/54399 · Cited by 4
Okada, K., Furusyo, N., Ogawa, E., Ikezaki, H., Ihara, T., Hayashi, T., Kainuma, M., Murata, M., & Hayashi, J. (2012) · Endocrine · doi:10.1007/s12020-012-9688-x · Cited by 5
Improvement of left ventricular systolic function in inflammatory cardiomyopathy: What plays a role?
Krejčí, J., Hude, P., Ozábalová, E., Mlejnek, D., Žampachová, V., Svobodova, I., Štěpánová, R., & Špinarová, L. (2016) · Biomedical Papers · doi:10.5507/bp.2016.033 · Cited by 5
Inflammatorische Kardiomyopathie und Myokarditis
Maisch, B., Ristić, A. D., & Pankuweit, S. (2017) · Herz · doi:10.1007/s00059-017-4569-y · Cited by 5
IL-27Genetic Variation and Susceptibility of Dilated Cardiomyopathy in Chinese Han Population
Chen, Y., Zhang, R., Zeng, L., Wei, H., Yang, C., & Jianhui, Z. (2017) · Personalized Medicine · doi:10.2217/pme-2017-0013 · Cited by 5
Blagova, O. V., Av, N., Коган, Е. А., & Sulimov, V. A. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh201789857-67 · Cited by 5
Mason, J. W., Trehan, S., & Renlund, D. G. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_62 · Cited by 7
Section 16: Myocarditis: Current Treatment
Heart Failure Society of America (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.11.021 · Cited by 5
Toubo, T., Ohga, S., Takada, H., Suga, N., Nomura, A., Ohno, T., & Hara, T. (2005) · Acta Paediatrica · doi:10.1080/08035250500371821 · Cited by 5
Cardiomyopathies and Myocarditis
Harrington, C. M., & Kasper, E. K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_33 · Cited by 5
Diagnosis and management of viral myocarditis
Frishman, W. H., Zeidner, J. F., & Naseer, N. (2007) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-007-0040-3 · Cited by 5
Ultrasound-guided serial transabdominal cardiac biopsies in cats
van Essen, V. J., Uilenreef, J. J., Szatmári, V., Kroeze, E. J. B. V., Kuiper, R., Rothuizen, J. J., & de Bruin, A. (2011) · The Veterinary Journal · doi:10.1016/j.tvjl.2011.02.022 · Cited by 5
Cardiovascular Viral Infections
Schultheiß, H., & Kühl, U. (2010) · Infectious disease and therapy · doi:10.3109/9781420084962.018 · Cited by 5
Pieroni, M., Notarstefano, P., Ciabatti, M., Nesti, M., Martinese, L., Liïstro, F., & Bolognese, L. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14014 · Cited by 7
Self-citationRose, N. R., & Čiháková, D. (2004) · Autoimmunity · doi:10.1080/08916930410001705457 · Cited by 5
Diagnostic Dilemmas and Management of Fulminant Myocarditis
Ahmar, W., Leet, A. S., & Morton, J. B. (2007) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0703500119 · Cited by 5
Cytopathic pathways of enteroviral myocardial infection
Frustaci, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp569 · Cited by 5
Self-citationScalone, G., & Niccoli, G. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1077114 · Cited by 4
Thiene, G. (2024) · Biomedicines · doi:10.3390/biomedicines12040832 · Cited by 4
Self-citationGroup B Coxsackievirus Diseases
Tracy, S., & Chapman, N. M. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch22 · Cited by 4
Aretz, H. T., & Kradin, R. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-3429-2.00008-0 · Cited by 4
Toubo, T., Ohga, S., Takada, H., Suga, N., Nomura, A., Ohno, T., & Hara, T. (2006) · Acta Paediatrica · doi:10.1111/j.1651-2227.2006.tb02291.x · Cited by 4
Kishimoto, C., Ohmae, M., & Tomioka, N. (2006) · Cardiovascular Pathology · doi:10.1016/j.carpath.2006.02.001 · Cited by 4
New Trends in the Development of Treatments of Viral Myocarditis
Yang, D., Zhang, H. M., Ye, X., Zhang, L., & Dai, H. (2013) · InTech eBooks · doi:10.5772/54103 · Cited by 4
Genetic Determinants of Virulence in the Group B Coxsackieviruses
Kim, K., Kanno, T., Chapman, N. M., & Tracy, S. (2006) · Future Virology · doi:10.2217/17460794.1.5.597 · Cited by 4
Immunotherapies for acute viral myocarditis in the pediatric patient
Feltes, T. F., & Adatia, I. (2006) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000244337.52057.7d · Cited by 4
Inflammatory cardiomyopathy: current concepts regarding its diagnosis and treatment
Kuchynka, P., Paleček, T., Šimek, S., Vítková, I., Schramlová, J., Hulinska, D., Aster, V., Dostálová, G., Magage, S., Aschermann, M., et al. (2009) · Cor et Vasa · doi:10.33678/cor.2009.009 · Cited by 4
Richer, M. J., Poffenberger, M. C., & Horwitz, M. S. (2007) · Future Virology · doi:10.2217/17460794.2.3.283 · Cited by 4
Mononuclear cell secretome in autoimmune myocarditis
Skurk, C., & Schultheiß, H. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht050 · Cited by 4
HIVAC ( HIV ‐associated cardiomyopathy): An overlooked complication of HIV in developing countries
Kharel, M., Subedi, A., & Hossain, M. F. (2024) · Clinical Case Reports · doi:10.1002/ccr3.9483 · Cited by 3
Genetic association of IL-21 polymorphisms with dilated cardiomyopathy in a Han Chinese population
Lin, J., Peng, Y., Zhou, B., Dou, Q., Li, Y., Yang, H., Zhang, L., & Rao, L. (2014) · Herz · doi:10.1007/s00059-013-4039-0 · Cited by 3
Cheitlin, M. D. (2007) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)70239-9 · Cited by 3
BURKE, A. P., & Virmani, R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3966-2.00018-7 · Cited by 3
Myocardites, intoxications et ECMO
Baud, F. J., Tournoux, F., & Deye, N. (2010) · Springer eBooks · doi:10.1007/978-2-287-99773-0_6 · Cited by 3
Blagova, O. V., Av, N., Парисович, С. В., Zaitsev, A. Y., Novosadov, V. M., & Коган, Е. А. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2637 · Cited by 3
Combes, A. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.03.006 · Cited by 4
Section 16: Myocarditis: Current Treatment
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.05.025 · Cited by 3
A Case of Fulminant Lymphocytic Myocarditis Responsive to Immunosuppression
Reiff, C., & Missov, E. D. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.06.021 · Cited by 3
Novel Therapeutic Targets in Viral Myocarditis
Miyamoto, S. D., DeBiasi, R. L., & Long, C. S. (2008) · Future Virology · doi:10.2217/17460794.3.4.373 · Cited by 3
Myocarditis and Dilated Cardiomyopathy
Rose, N. R., & Kaya, Z. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00070-8 · Cited by 3
Antonelli, A., Ferri, C., Ferrari, S., Domenicantonio, A. D., Mancusi, C., Marchi, S., de Bortoli, N., Metelli, M. R., Bruschi, F., & Fallahi, P. (2012) · European Journal of Inflammation · doi:10.1177/1721727x1201000117 · Cited by 3
Organ-Specific Autoimmune Myocardial Diseases
Caforio, A. L. P., Marcolongo, R., Malipiero, G., Agostini, C., Seguso, M., Gallo, N., Plebani, M., & Iliceto, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00002-8 · Cited by 3
Pathophysiological Mechanisms of Parvovirus B19 Infection
Noutsias, M., Pankuweit, S., & Maisch, B. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00580-09 · Cited by 3
Mechanisms of autoimmune heart disease
Eriksson, U., Penninger, J. M., & Köpf, M. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.11.011 · Cited by 3
Baritussio, A., Giordani, A. S., Rizzo, S., Vicenzetto, C., Gaspari, M. D., Carturan, E., Toscano, G., Scognamiglio, F., Tarantini, G., Iliceto, S., et al. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15349 · Cited by 2
Emerging Treatments for Viral Myocarditis
Matsumori, A. (2005) · Future Cardiology · doi:10.2217/14796678.1.5.683 · Cited by 2
Dilated cardiomyopathy may develop in patients with Aspergillus infection
Yano, S. (2010) · Respiratory Medicine CME · doi:10.1016/j.rmedc.2009.11.004 · Cited by 2
Dec, G. W. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_2 · Cited by 2
FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy
Makrutzki-Zlotek, K., Escher, F., Karadeniz, Z., Aleshcheva, G., Pietsch, H., Küchler, K., Schultheiß, H., Heidecker, B., Poller, W. C., Landmesser, U., et al. (2023) · Heart · doi:10.1136/heartjnl-2022-321732 · Cited by 2
Dolader, P., Corrales, D. C. J., Esmel-Vilomara, R., Daina, C., Izquierdo-Blasco, J., Fernandez, E., Garrido‐Pontnou, M., Navarro, A., Camacho, J., Fidalgo, A., et al. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06424-x · Cited by 2
Stand der Diagnostik und Therapie der inflammatorischen Kardiomyopathie
Schultheiss, H.-P., & Kühl, U. (2008) · Der Internist · doi:10.1007/s00108-007-1966-y · Cited by 3
Immunomodulatory and Immunoadsorptive Treatments
Staudt, A., & Felix, S. B. (2005) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.06.008 · Cited by 2
Fighting the flu: The rise of the machine*
Dalton, H. J. (2004) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000128886.08534.9e · Cited by 2
The Role of IL-17 in Experimental Autoimmune Myocarditis
Eriksson, U. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_12 · Cited by 2
Immunosuppressive therapy in inflammatory cardiomyopathy
Frustaci, A. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90114-8 · Cited by 2
Self-citationCostanzo, C. M., Monte, I. P., Zappal, D., Palermo, C. I., Span, S., Russo, R., Oliveri, S. M., Patamia, I., & Scalia, G. (2011) · PubMed · Cited by 2
Pharmacologic Management of Heart Failure in the Ambulatory Setting
Givertz, M. M., & Cohn, J. N. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50020-6 · Cited by 2
Diagnosis and Treatment of Myocarditis
Milei, J., & Ambrosio, G. (2013) · InTech eBooks · doi:10.5772/46013 · Cited by 2
Mou, S. S., & McCrory, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-1-4557-0760-7.00028-0 · Cited by 2
Pharmacologic Management of Heart Failure in the Ambulatory Setting
Givertz, M. M., & Cohn, J. N. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00012-6 · Cited by 2
Myocarditis and Inflammatory Cardiomyopathy
Bobbio, E., & Karason, K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98998 · Cited by 2
Coxsackievirus-induced murine myocarditis and immunomodulatory interventions
Noutsias, M., & Liu, P. X. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_4 · Cited by 2
Anti-viral Treatment in Patients with Virus-Induced Cardiomyopathy
Kühl, U., Pauschinger, M., Poller, W. C., & Schultheiß, H. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_18 · Cited by 2
Immunosuppressive Therapy for Heart Failure
Nowalany-Kozielska, E., & Wojnicz, R. (2003) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200303050-00003 · Cited by 2
Heidecker, B., & Cooper, L. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52993-8.00019-9 · Cited by 2
Spezifische Therapie der inflammatorischen Kardiomyopathie und viralen Herzerkrankungen
Kühl, U., & Hp, S. (2011) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Invited for Debate: Is Virus Persistence a Determinant for Disease Progression?
Keren, A. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_4 · Cited by 2
Blagova, O. V., Нуховна, А. И., Kulikova, V., Nedostup, A. V., Коган, Е. А., Парисович, С. В., Parfenov, D. A., Volovchenko, A. N., & Sarkisova, N. D. (2023) · Terapevticheskii arkhiv · doi:10.26442/00403660.2023.04.202156 · Cited by 1
Zhang, J., Zhan, H., Xu, H., Wang, R., Li, Z., Feng, F., Wu, H., Xu, Z., Wang, S., Guo, Y., et al. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103860 · Cited by 1
“Bridging the clinical, molecular and genetic perspectives on myocarditis in post-COVID-19 era”
Birla, S., Angural, A., Madathumchalil, A., Shende, R. V., Shastry, S. V., Shekar, P. K., Mahadevappa, M., Vishwanath, P. M., & Prashant, A. (2026) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2026.200576 · Cited by 1
Noutsias, M., Schultheiß, H., & Kühl, U. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_10 · Cited by 1
Heart Response to Inflammation and Infection
Marı́n-Garcı́a, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50014-0 · Cited by 1
Immunosuppressive Therapy for Heart Failure
Wojnicz, R. (2005) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.06.009 · Cited by 1
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., Johnson, M. R., et al. (2013) · Cited by 1
Molecular Pathobiology of Myocarditis
Carturan, E., Basso, C., & Thiene, G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405206-2.00008-9 · Cited by 1
Self-citationKradin, R. L., & Aretz, H. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44585-6.00009-6 · Cited by 1
Kuchynka, P., Paleček, T., Šimek, S., Horák, J., Vítková, I., Schramlová, J., Hulinska, D., Aster, V., Aschermann, M., & Linhart, A. (2009) · Cor et Vasa · doi:10.33678/cor.2009.141 · Cited by 1
Immunosuppressive Therapy in Myocarditis: Lessons from Clinical Trials and Future Perspectives
Frustaci, A., & Chimenti, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_14 · Cited by 1
Self-citationMyokarditis: Meist mit Defektheilung
Tschöpe, C., & Kühl, U. (2015) · Deutsches Ärzteblatt · doi:10.3238/perskardio.2015.09.18.06 · Cited by 1
Domínguez, F., Paz, R. C., Antón, C. S., Iess, M. C., Domínguez, J. F. O., Escobar-López, L., de Frutos, F., Marcos, M. C., González-López, E., Hernández-Pérez, F. J., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2022.01.010 · Cited by 1
The role of IL-17 in experimental autoimmune myocarditis
Valaperti, A., & Eriksson, U. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8681-8_10 · Cited by 1
DIAGNOSIS AND TREATMENT OF MYOCARDITIS
Arsahanova, G. A. (2022) · Международный журнал прикладных наук и технологий «Integral» · doi:10.55186/02357801_2022_7_1_33 · Cited by 1
Autoimmune Murine Myocarditis and Immunomodulatory Interventions
Berger, C. T., & Eriksson, U. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_3 · Cited by 1
Sénior, J. M. (2008) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1
New Therapeutics Targets in Chronic Viral Cardiomyopathy
Poller, W. C., Fechner, H., Kühl, U., Pauschinger, M., & Schultheiss, H.-P. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_16 · Cited by 1
Nucleic Acid-Based Strategies for the Treatment of Coxsackievirus-Induced Myocarditis
Yang, D. (2011) · InTech eBooks · doi:10.5772/19240 · Cited by 1
Cheitlin, M. D. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70219-8 · Cited by 1
Heart Failure as a Consequence of Viral and Nonviral Myocarditis
Pereira, N. L., & Cooper, L. T. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10031-2 · Cited by 2
Antiviral Therapies: A Critical Reappraisal
Elsanhoury, A., Linthout, S. V., & Tschöpe, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_17 · Cited by 1
Mechanisms underlying Myocarditis
Rose, N. R., Čiháková, D., & Barin, J. G. (2006) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2006.05.008 · Cited by 1
Pieroni, M., Chimenti, C., & Frustaci, A. (2005) · Circulation · doi:10.1161/01.cir.0000153421.88823.c6 · Cited by 1
Self-citationThe Therapeutic Potential of Immune Therapy in Idiopathic Dilated Cardiomyopathy
Mobini, R., & Andersson, B. (2005) · Future Cardiology · doi:10.2217/14796678.1.5.675 · Cited by 1
Immune Mechanisms in Pediatric Cardiovascular Disease
Luce, W. A., Joshi, M. S., Hoffman, T. M., Feltes, T. F., & Bauer, J. A. (2007) · doi:10.1002/9780470692325.ch2 · Cited by 1
Santangeli, P., Marzo, F., Macchione, A., Bellocci, F., Crea, F., & Pieroni, M. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.03.027 · Cited by 1
Self-citationKapoor, J. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmc091013 · Cited by 1
Antiviral interferon-β treatment in patients with chronic viral cardiomyopathy
Schultheiß, H., Noutsias, M., & Kühl, U. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_14
Heart Failure—Role of Autoimmunity
Eriksson, U. (2007) · Wiley eBooks · doi:10.1002/9780470692325.ch3
Miocarditis simula infarto agudo del miocardio en paciente con varicela
Valdés, T., Pérez, A. S., López, L. L., & Hernández, A. V. (2013) · Revista panorama/Panorama. Cuba y salud
Metadata
- Authors
- Frustaci, A., Chimenti, C., Calabrese, F., Pieroni, M., Thiene, G., & Maseri, A.
- Affiliations
- University of Padua (IT)
- Venue
- Circulation
- Published
- 2003-02-18
- Volume
- 107
- Issue
- 6
- Pages
- 857-863
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1968165176
- Cited by
- 462
- References
- 23
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 15 · 2023: 11 · 2022: 14 · 2021: 11 · 2020: 17 · 2019: 17 · 2018: 10 · 2017: 21 · 2016: 15 · 2015: 11 · 2014: 20 · 2013: 27 · 2012: 23
- FWCI
- 21.60
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Pericarditis and Cardiac Tamponade
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- lymphocytic myocarditis, immunosuppressive therapy, prednisone, azathioprine, heart failure, cardiac autoantibodies, viral myocarditis, endomyocardial biopsy, dilated cardiomyopathy, treatment response
- MeSH terms
- Adolescent, Adult, Autoantibodies, Azathioprine, Biopsy, Cardiotonic Agents, Chronic Disease, Echocardiography, Female, Follow-Up Studies, Heart, Heart Failure, Hemodynamics, Humans, Immunosuppressive Agents, Lymphocytes, Male, Middle Aged, Myocarditis, Myocardium, Prednisone, Retrospective Studies, Severity of Illness Index, Stroke Volume, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
